Association Between Recombinant Growth Hormone Therapy and All-Cause Mortality and Cancer Risk in Childhood: Systematic Review and Meta-Analysis

Association Between Recombinant Growth Hormone Therapy and All-Cause Mortality and Cancer Risk in Childhood: Systematic Review and Meta-Analysis

ObjectivesThe safety of recombinant human growth hormone (rhGH) treatment in childhood and the role of rhGH therapy in promoting tumorigenesis and progression have been the subject of debate for decades. We aimed to systematically assess the relationship between rhGH therapy in children and adolesce...

Full description

Bibliographic Details
Main Authors: Mengyang He, Xiangling Deng, Xuan Wang, Yuxiang Wan, Jinchang Huang, Zhixin Zhang, Wenquan Niu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Pediatrics
Subjects:
mortality
children
cancer
medication safety
rhGH
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.866295/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.866295/full

Similar Items